JP2013511990A - 末端置換を含むｓｉＲＮＡ化合物 - Google Patents

Info

Publication number

JP2013511990A

JP2013511990A JP2012541211A JP2012541211A JP2013511990A JP 2013511990 A JP2013511990 A JP 2013511990A JP 2012541211 A JP2012541211 A JP 2012541211A JP 2012541211 A JP2012541211 A JP 2012541211A JP 2013511990 A JP2013511990 A JP 2013511990A

Authority

JP

Japan

Prior art keywords

double

nucleic acid

modified

acid molecule

nucleotide

Prior art date

2009-11-26

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108020004459 Small interfering RNA Proteins 0.000 title claims abstract description 225
• 150000001875 compounds Chemical class 0.000 title abstract description 152
• 238000006467 substitution reaction Methods 0.000 title description 6
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 85
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 78
• 201000010099 disease Diseases 0.000 claims abstract description 65
• 238000000034 method Methods 0.000 claims abstract description 59
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 36
• 208000024891 symptom Diseases 0.000 claims abstract description 10
• 125000003729 nucleotide group Chemical group 0.000 claims description 271
• 239000002773 nucleotide Substances 0.000 claims description 243
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 168
• 230000000692 anti-sense effect Effects 0.000 claims description 91
• 125000002652 ribonucleotide group Chemical group 0.000 claims description 89
• 230000000694 effects Effects 0.000 claims description 74
• 102000039446 nucleic acids Human genes 0.000 claims description 74
• 108020004707 nucleic acids Proteins 0.000 claims description 74
• 150000007523 nucleic acids Chemical class 0.000 claims description 66
• 108020004999 messenger RNA Proteins 0.000 claims description 63
• 230000000295 complement effect Effects 0.000 claims description 61
• -1 deoxyribouridine Natural products 0.000 claims description 61
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims description 56
• 235000000346 sugar Nutrition 0.000 claims description 54
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 48
• 229960005305 adenosine Drugs 0.000 claims description 45
• 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 43
• 229910052757 nitrogen Inorganic materials 0.000 claims description 41
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 38
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 35
• 108091081021 Sense strand Proteins 0.000 claims description 35
• 125000000217 alkyl group Chemical group 0.000 claims description 35
• 238000011282 treatment Methods 0.000 claims description 32
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims description 26
• 238000002054 transplantation Methods 0.000 claims description 26
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims description 26
• 229940045145 uridine Drugs 0.000 claims description 26
• 230000009368 gene silencing by RNA Effects 0.000 claims description 25
• 108020004414 DNA Proteins 0.000 claims description 24
• 108091034117 Oligonucleotide Proteins 0.000 claims description 24
• MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 claims description 23
• MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 claims description 23
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 20
• 208000009304 Acute Kidney Injury Diseases 0.000 claims description 18
• 208000033626 Renal failure acute Diseases 0.000 claims description 18
• 201000011040 acute kidney failure Diseases 0.000 claims description 18
• 206010028980 Neoplasm Diseases 0.000 claims description 16
• 208000012998 acute renal failure Diseases 0.000 claims description 16
• 210000004072 lung Anatomy 0.000 claims description 16
• DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 claims description 16
• 208000010038 Ischemic Optic Neuropathy Diseases 0.000 claims description 14
• 206010030924 Optic ischaemic neuropathy Diseases 0.000 claims description 14
• 208000016354 hearing loss disease Diseases 0.000 claims description 14
• 210000001328 optic nerve Anatomy 0.000 claims description 14
• 208000010412 Glaucoma Diseases 0.000 claims description 13
• 201000007058 anterior ischemic optic neuropathy Diseases 0.000 claims description 13
• 150000003838 adenosines Chemical group 0.000 claims description 12
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 12
• 208000020431 spinal cord injury Diseases 0.000 claims description 12
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 11
• 208000004210 Pressure Ulcer Diseases 0.000 claims description 11
• 206010063837 Reperfusion injury Diseases 0.000 claims description 11
• 210000003734 kidney Anatomy 0.000 claims description 11
• 206010011878 Deafness Diseases 0.000 claims description 10
• 230000010370 hearing loss Effects 0.000 claims description 10
• 231100000888 hearing loss Toxicity 0.000 claims description 10
• 210000000056 organ Anatomy 0.000 claims description 10
• 230000002194 synthesizing effect Effects 0.000 claims description 10
• 239000003937 drug carrier Substances 0.000 claims description 9
• 208000028867 ischemia Diseases 0.000 claims description 9
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 8
• 230000000302 ischemic effect Effects 0.000 claims description 8
• 208000002780 macular degeneration Diseases 0.000 claims description 8
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 7
• 201000011510 cancer Diseases 0.000 claims description 7
• 230000006378 damage Effects 0.000 claims description 7
• 230000004064 dysfunction Effects 0.000 claims description 7
• 208000014674 injury Diseases 0.000 claims description 7
• 239000002679 microRNA Substances 0.000 claims description 7
• 208000027418 Wounds and injury Diseases 0.000 claims description 6
• 208000029028 brain injury Diseases 0.000 claims description 6
• 230000004044 response Effects 0.000 claims description 6
• 208000003265 stomatitis Diseases 0.000 claims description 6
• 208000003556 Dry Eye Syndromes Diseases 0.000 claims description 5
• 206010013774 Dry eye Diseases 0.000 claims description 5
• 206010030113 Oedema Diseases 0.000 claims description 5
• 206010064930 age-related macular degeneration Diseases 0.000 claims description 5
• 238000000137 annealing Methods 0.000 claims description 5
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims description 5
• 230000000241 respiratory effect Effects 0.000 claims description 5
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims description 4
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims description 4
• 230000001154 acute effect Effects 0.000 claims description 4
• 210000002216 heart Anatomy 0.000 claims description 4
• 208000012947 ischemia reperfusion injury Diseases 0.000 claims description 4
• 230000004770 neurodegeneration Effects 0.000 claims description 4
• 230000004768 organ dysfunction Effects 0.000 claims description 4
• 230000010410 reperfusion Effects 0.000 claims description 4
• 238000002560 therapeutic procedure Methods 0.000 claims description 4
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 3
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 3
• 244000089409 Erythrina poeppigiana Species 0.000 claims description 3
• 235000009776 Rathbunia alamosensis Nutrition 0.000 claims description 3
• 230000003176 fibrotic effect Effects 0.000 claims description 3
• 229940029575 guanosine Drugs 0.000 claims description 3
• 101150054147 sina gene Proteins 0.000 claims description 3
• 206010029155 Nephropathy toxic Diseases 0.000 claims description 2
• 206010029350 Neurotoxicity Diseases 0.000 claims description 2
• 206010044221 Toxic encephalopathy Diseases 0.000 claims description 2
• 206010060872 Transplant failure Diseases 0.000 claims description 2
• 210000004185 liver Anatomy 0.000 claims description 2
• 230000007694 nephrotoxicity Effects 0.000 claims description 2
• 231100000417 nephrotoxicity Toxicity 0.000 claims description 2
• 230000007135 neurotoxicity Effects 0.000 claims description 2
• 231100000228 neurotoxicity Toxicity 0.000 claims description 2
• 210000000496 pancreas Anatomy 0.000 claims description 2
• 230000002378 acidificating effect Effects 0.000 claims 3
• 108091030071 RNAI Proteins 0.000 claims 2
• 108091070501 miRNA Proteins 0.000 claims 1
• 201000002761 non-arteritic anterior ischemic optic neuropathy Diseases 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 230000014509 gene expression Effects 0.000 abstract description 44
• 239000004055 small Interfering RNA Substances 0.000 description 212
• 230000004048 modification Effects 0.000 description 62
• 238000012986 modification Methods 0.000 description 62
• 210000004027 cell Anatomy 0.000 description 47
• 108091028664 Ribonucleotide Proteins 0.000 description 45
• 239000002336 ribonucleotide Substances 0.000 description 45
• 229920002477 rna polymer Polymers 0.000 description 40
• 238000012360 testing method Methods 0.000 description 38
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 36
• 239000000203 mixture Substances 0.000 description 33
• 208000035657 Abasia Diseases 0.000 description 28
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 23
• 102000053602 DNA Human genes 0.000 description 22
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 21
• KKZFLSZAWCYPOC-VPENINKCSA-N Deoxyribose 5-phosphate Chemical group O[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KKZFLSZAWCYPOC-VPENINKCSA-N 0.000 description 17
• 102000008228 Toll-like receptor 2 Human genes 0.000 description 16
• 108010060888 Toll-like receptor 2 Proteins 0.000 description 16
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 16
• 108010052090 Renilla Luciferases Proteins 0.000 description 15
• 239000005547 deoxyribonucleotide Substances 0.000 description 15
• 239000003814 drug Substances 0.000 description 15
• MHZDONKZSXBOGL-UHFFFAOYSA-N propyl dihydrogen phosphate Chemical compound CCCOP(O)(O)=O MHZDONKZSXBOGL-UHFFFAOYSA-N 0.000 description 15
• 239000013598 vector Substances 0.000 description 15
• 241001465754 Metazoa Species 0.000 description 12
• 241000700159 Rattus Species 0.000 description 12
• 208000035475 disorder Diseases 0.000 description 12
• 238000001890 transfection Methods 0.000 description 12
• 238000009472 formulation Methods 0.000 description 11
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 11
• 102100029398 Calpain small subunit 1 Human genes 0.000 description 10
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 10
• 238000010171 animal model Methods 0.000 description 10
• 230000003828 downregulation Effects 0.000 description 10
• 150000002430 hydrocarbons Chemical group 0.000 description 10
• 230000005764 inhibitory process Effects 0.000 description 10
• 206010014561 Emphysema Diseases 0.000 description 9
• 101000919194 Homo sapiens Calpain small subunit 1 Proteins 0.000 description 9
• 241000124008 Mammalia Species 0.000 description 9
• 108091093037 Peptide nucleic acid Proteins 0.000 description 9
• 230000015572 biosynthetic process Effects 0.000 description 9
• ZEXSWWSPNTYEJC-UHFFFAOYSA-N dihydroxy-propoxy-sulfanylidene-$l^{5}-phosphane Chemical compound CCCOP(O)(O)=S ZEXSWWSPNTYEJC-UHFFFAOYSA-N 0.000 description 9
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 9
• 230000009437 off-target effect Effects 0.000 description 9
• XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 9
• 108090000765 processed proteins & peptides Proteins 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• 206010012689 Diabetic retinopathy Diseases 0.000 description 8
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 8
• 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 8
• 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 8
• 230000006907 apoptotic process Effects 0.000 description 8
• 229940104302 cytosine Drugs 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 208000009386 Experimental Arthritis Diseases 0.000 description 7
• 108090001126 Furin Proteins 0.000 description 7
• 229910019142 PO4 Inorganic materials 0.000 description 7
• 101150111584 RHOA gene Proteins 0.000 description 7
• 239000012634 fragment Substances 0.000 description 7
• 239000003112 inhibitor Substances 0.000 description 7
• 238000001990 intravenous administration Methods 0.000 description 7
• 230000001404 mediated effect Effects 0.000 description 7
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 7
• 150000004713 phosphodiesters Chemical class 0.000 description 7
• 210000001525 retina Anatomy 0.000 description 7
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 7
• 230000008685 targeting Effects 0.000 description 7
• 229940124597 therapeutic agent Drugs 0.000 description 7
• 108020005345 3' Untranslated Regions Proteins 0.000 description 6
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 6
• 239000005977 Ethylene Substances 0.000 description 6
• 108700011259 MicroRNAs Proteins 0.000 description 6
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 6
• 208000017442 Retinal disease Diseases 0.000 description 6
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 6
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 6
• 210000004556 brain Anatomy 0.000 description 6
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
• 206010012601 diabetes mellitus Diseases 0.000 description 6
• 230000030279 gene silencing Effects 0.000 description 6
• 230000006872 improvement Effects 0.000 description 6
• 208000017169 kidney disease Diseases 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 239000010452 phosphate Substances 0.000 description 6
• 235000021317 phosphate Nutrition 0.000 description 6
• 229910052698 phosphorus Inorganic materials 0.000 description 6
• 239000011574 phosphorus Substances 0.000 description 6
• 239000013612 plasmid Substances 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 229940035893 uracil Drugs 0.000 description 6
• 241000700112 Chinchilla Species 0.000 description 5
• 206010011985 Decubitus ulcer Diseases 0.000 description 5
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
• 206010029113 Neovascularisation Diseases 0.000 description 5
• 206010069385 Ocular ischaemic syndrome Diseases 0.000 description 5
• 108700008625 Reporter Genes Proteins 0.000 description 5
• 206010038923 Retinopathy Diseases 0.000 description 5
• 208000006011 Stroke Diseases 0.000 description 5
• 206010047115 Vasculitis Diseases 0.000 description 5
• 230000009286 beneficial effect Effects 0.000 description 5
• 239000003153 chemical reaction reagent Substances 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 5
• 230000002222 downregulating effect Effects 0.000 description 5
• 210000002592 gangliocyte Anatomy 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 238000003752 polymerase chain reaction Methods 0.000 description 5
• 102000004169 proteins and genes Human genes 0.000 description 5
• 210000003994 retinal ganglion cell Anatomy 0.000 description 5
• 210000000278 spinal cord Anatomy 0.000 description 5
• 208000011580 syndromic disease Diseases 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 4
• PGSPUKDWUHBDKJ-UHFFFAOYSA-N 6,7-dihydro-3h-purin-2-amine Chemical compound C1NC(N)=NC2=C1NC=N2 PGSPUKDWUHBDKJ-UHFFFAOYSA-N 0.000 description 4
• 208000024827 Alzheimer disease Diseases 0.000 description 4
• 206010006458 Bronchitis chronic Diseases 0.000 description 4
• 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 4
• 102100032616 Caspase-2 Human genes 0.000 description 4
• 208000025962 Crush injury Diseases 0.000 description 4
• 108090000331 Firefly luciferases Proteins 0.000 description 4
• 102100040557 Osteopontin Human genes 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• 229920002873 Polyethylenimine Polymers 0.000 description 4
• 238000011529 RT qPCR Methods 0.000 description 4
• 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 4
• 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 4
• 102100022387 Transforming protein RhoA Human genes 0.000 description 4
• 206010052779 Transplant rejections Diseases 0.000 description 4
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
• 239000004480 active ingredient Substances 0.000 description 4
• 206010069351 acute lung injury Diseases 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 4
• 230000033115 angiogenesis Effects 0.000 description 4
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Chemical group O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
• 238000010322 bone marrow transplantation Methods 0.000 description 4
• 206010006451 bronchitis Diseases 0.000 description 4
• 208000015114 central nervous system disease Diseases 0.000 description 4
• 208000007451 chronic bronchitis Diseases 0.000 description 4
• 238000003776 cleavage reaction Methods 0.000 description 4
• 238000010367 cloning Methods 0.000 description 4
• DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 208000030533 eye disease Diseases 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 210000000067 inner hair cell Anatomy 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 201000008482 osteoarthritis Diseases 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 239000001294 propane Substances 0.000 description 4
• 238000011084 recovery Methods 0.000 description 4
• 230000002207 retinal effect Effects 0.000 description 4
• 208000004644 retinal vein occlusion Diseases 0.000 description 4
• 230000007017 scission Effects 0.000 description 4
• 239000011550 stock solution Substances 0.000 description 4
• 238000001356 surgical procedure Methods 0.000 description 4
• 230000004083 survival effect Effects 0.000 description 4
• 229940104230 thymidine Drugs 0.000 description 4
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
• 230000000699 topical effect Effects 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• 239000012224 working solution Substances 0.000 description 4
• 102100029592 Activator of apoptosis harakiri Human genes 0.000 description 3
• 229930024421 Adenine Natural products 0.000 description 3
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
• 102100021986 Apoptosis-stimulating of p53 protein 2 Human genes 0.000 description 3
• 102100035656 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 Human genes 0.000 description 3
• 206010011903 Deafness traumatic Diseases 0.000 description 3
• 208000007342 Diabetic Nephropathies Diseases 0.000 description 3
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 3
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• 102000019058 Glycogen Synthase Kinase 3 beta Human genes 0.000 description 3
• 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 3
• 101000987827 Homo sapiens Activator of apoptosis harakiri Proteins 0.000 description 3
• 101000803294 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 Proteins 0.000 description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
• 241000699670 Mus sp. Species 0.000 description 3
• 208000002946 Noise-Induced Hearing Loss Diseases 0.000 description 3
• 208000022873 Ocular disease Diseases 0.000 description 3
• 208000005718 Stomach Neoplasms Diseases 0.000 description 3
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 3
• 229960000643 adenine Drugs 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• 239000000443 aerosol Substances 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 230000002491 angiogenic effect Effects 0.000 description 3
• 150000008209 arabinosides Chemical class 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 3
• 125000002619 bicyclic group Chemical group 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 229960004562 carboplatin Drugs 0.000 description 3
• 235000012000 cholesterol Nutrition 0.000 description 3
• 208000019425 cirrhosis of liver Diseases 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 208000033679 diabetic kidney disease Diseases 0.000 description 3
• 231100000673 dose–response relationship Toxicity 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 210000005069 ears Anatomy 0.000 description 3
• 125000001153 fluoro group Chemical group F* 0.000 description 3
• DVGHHMFBFOTGLM-UHFFFAOYSA-L fluorogold Chemical compound F[Au][Au]F DVGHHMFBFOTGLM-UHFFFAOYSA-L 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 3
• 206010017758 gastric cancer Diseases 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 210000002768 hair cell Anatomy 0.000 description 3
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 201000007270 liver cancer Diseases 0.000 description 3
• 208000014018 liver neoplasm Diseases 0.000 description 3
• 201000005202 lung cancer Diseases 0.000 description 3
• 208000020816 lung neoplasm Diseases 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 210000000274 microglia Anatomy 0.000 description 3
• 238000013059 nephrectomy Methods 0.000 description 3
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
• ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 3
• 230000001766 physiological effect Effects 0.000 description 3
• 230000032361 posttranscriptional gene silencing Effects 0.000 description 3
• ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 3
• 239000000700 radioactive tracer Substances 0.000 description 3
• 208000023504 respiratory system disease Diseases 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 201000011549 stomach cancer Diseases 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 3
• 238000011200 topical administration Methods 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• YROJWWHYHBKDPB-VEGRVEBRSA-N (2r,3r,4r)-2,3,4,5-tetrahydroxypentanal;trihydroxy(sulfanylidene)-$l^{5}-phosphane Chemical compound OP(O)(O)=S.OC[C@@H](O)[C@@H](O)[C@@H](O)C=O YROJWWHYHBKDPB-VEGRVEBRSA-N 0.000 description 2
• 102100027769 2'-5'-oligoadenylate synthase 1 Human genes 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 2
• 102100021987 Apoptosis-stimulating of p53 protein 1 Human genes 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 description 2
• LACKJDXLNKDOKJ-UHFFFAOYSA-N CCCOP(O)(=O)OCCCP(=O)=O Chemical compound CCCOP(O)(=O)OCCCP(=O)=O LACKJDXLNKDOKJ-UHFFFAOYSA-N 0.000 description 2
• YDEQDAFOTKIGKR-UHFFFAOYSA-N CCCOP(O)(=S)OCCCP(=O)=O Chemical compound CCCOP(O)(=S)OCCCP(=O)=O YDEQDAFOTKIGKR-UHFFFAOYSA-N 0.000 description 2
• 108010032088 Calpain Proteins 0.000 description 2
• 102000007590 Calpain Human genes 0.000 description 2
• 239000004215 Carbon black (E152) Substances 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 108090000552 Caspase-2 Proteins 0.000 description 2
• 208000002177 Cataract Diseases 0.000 description 2
• 208000005590 Choroidal Neovascularization Diseases 0.000 description 2
• 206010060823 Choroidal neovascularisation Diseases 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• 102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 2
• 102100025620 Cytochrome b-245 light chain Human genes 0.000 description 2
• 102100026139 DNA damage-inducible transcript 4 protein Human genes 0.000 description 2
• 108010083068 Dual Oxidases Proteins 0.000 description 2
• 102100021218 Dual oxidase 1 Human genes 0.000 description 2
• 206010058314 Dysplasia Diseases 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 102100035427 Forkhead box protein O1 Human genes 0.000 description 2
• 102100035416 Forkhead box protein O4 Human genes 0.000 description 2
• 108091093094 Glycol nucleic acid Proteins 0.000 description 2
• 206010019280 Heart failures Diseases 0.000 description 2
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 2
• 102100033985 Heterogeneous nuclear ribonucleoprotein D0 Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101001008907 Homo sapiens 2'-5'-oligoadenylate synthase 1 Proteins 0.000 description 2
• 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 2
• 101000752722 Homo sapiens Apoptosis-stimulating of p53 protein 1 Proteins 0.000 description 2
• 101000752711 Homo sapiens Apoptosis-stimulating of p53 protein 2 Proteins 0.000 description 2
• 101000867612 Homo sapiens Caspase-2 Proteins 0.000 description 2
• 101000856723 Homo sapiens Cytochrome b-245 light chain Proteins 0.000 description 2
• 101000912753 Homo sapiens DNA damage-inducible transcript 4 protein Proteins 0.000 description 2
• 101000877683 Homo sapiens Forkhead box protein O4 Proteins 0.000 description 2
• 101001002170 Homo sapiens Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial Proteins 0.000 description 2
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 2
• 101000697493 Homo sapiens Large proline-rich protein BAG6 Proteins 0.000 description 2
• 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 2
• 101001108225 Homo sapiens NADPH oxidase 3 Proteins 0.000 description 2
• 101100256651 Homo sapiens SENP6 gene Proteins 0.000 description 2
• 101000836383 Homo sapiens Serpin H1 Proteins 0.000 description 2
• 101000843556 Homo sapiens Transcription factor HES-1 Proteins 0.000 description 2
• 101000843449 Homo sapiens Transcription factor HES-5 Proteins 0.000 description 2
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
• 101001022129 Homo sapiens Tyrosine-protein kinase Fyn Proteins 0.000 description 2
• 101001129796 Homo sapiens p53-induced death domain-containing protein 1 Proteins 0.000 description 2
• 208000023105 Huntington disease Diseases 0.000 description 2
• 206010020772 Hypertension Diseases 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
• 229930010555 Inosine Natural products 0.000 description 2
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 2
• 102100028047 Large proline-rich protein BAG6 Human genes 0.000 description 2
• 108010051335 Lipocalin-2 Proteins 0.000 description 2
• 102000013519 Lipocalin-2 Human genes 0.000 description 2
• 239000012097 Lipofectamine 2000 Substances 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 2
• 108010082739 NADPH Oxidase 2 Proteins 0.000 description 2
• 102100021874 NADPH oxidase 3 Human genes 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 208000003435 Optic Neuritis Diseases 0.000 description 2
• 102100033344 Programmed cell death 6-interacting protein Human genes 0.000 description 2
• 108090000315 Protein Kinase C Proteins 0.000 description 2
• 102000003923 Protein Kinase C Human genes 0.000 description 2
• 101150058540 RAC1 gene Proteins 0.000 description 2
• 206010063897 Renal ischaemia Diseases 0.000 description 2
• 241000242739 Renilla Species 0.000 description 2
• 241000725643 Respiratory syncytial virus Species 0.000 description 2
• 206010038848 Retinal detachment Diseases 0.000 description 2
• 201000000582 Retinoblastoma Diseases 0.000 description 2
• 101150038317 SSP1 gene Proteins 0.000 description 2
• 101100125020 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pss1 gene Proteins 0.000 description 2
• 101100018019 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ssc1 gene Proteins 0.000 description 2
• 102100023713 Sentrin-specific protease 6 Human genes 0.000 description 2
• 102100021117 Serine protease HTRA2, mitochondrial Human genes 0.000 description 2
• 102100027287 Serpin H1 Human genes 0.000 description 2
• 108091027967 Small hairpin RNA Proteins 0.000 description 2
• 108091046915 Threose nucleic acid Proteins 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• 102100030798 Transcription factor HES-1 Human genes 0.000 description 2
• 102100030853 Transcription factor HES-5 Human genes 0.000 description 2
• 208000030886 Traumatic Brain injury Diseases 0.000 description 2
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
• 102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 description 2
• 102100037932 Ubiquitin D Human genes 0.000 description 2
• 208000025865 Ulcer Diseases 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 206010046851 Uveitis Diseases 0.000 description 2
• 108020000999 Viral RNA Proteins 0.000 description 2
• IMBYBANOLUYVCT-CRCLSJGQSA-N [(2r,3s)-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate Chemical compound OC[C@H]1OCC[C@@H]1OP(O)(O)=O IMBYBANOLUYVCT-CRCLSJGQSA-N 0.000 description 2
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 2
• 230000036982 action potential Effects 0.000 description 2
• 125000002015 acyclic group Chemical group 0.000 description 2
• LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 125000003545 alkoxy group Chemical group 0.000 description 2
• 210000001130 astrocyte Anatomy 0.000 description 2
• 210000003030 auditory receptor cell Anatomy 0.000 description 2
• 210000003050 axon Anatomy 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000008499 blood brain barrier function Effects 0.000 description 2
• 210000001218 blood-brain barrier Anatomy 0.000 description 2
• 210000003123 bronchiole Anatomy 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 208000020832 chronic kidney disease Diseases 0.000 description 2
• 230000004087 circulation Effects 0.000 description 2
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
• 229960004316 cisplatin Drugs 0.000 description 2
• 210000003477 cochlea Anatomy 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 230000000052 comparative effect Effects 0.000 description 2
• 229940109239 creatinine Drugs 0.000 description 2
• ZDPUTNZENXVHJC-UHFFFAOYSA-N cumingianoside D Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(OP(O)(O)=O)C1O ZDPUTNZENXVHJC-UHFFFAOYSA-N 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000005860 defense response to virus Effects 0.000 description 2
• 239000005549 deoxyribonucleoside Substances 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 239000003221 ear drop Substances 0.000 description 2
• 229940047652 ear drops Drugs 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 238000007824 enzymatic assay Methods 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 239000003889 eye drop Substances 0.000 description 2
• 229940012356 eye drops Drugs 0.000 description 2
• 230000004438 eyesight Effects 0.000 description 2
• 230000004761 fibrosis Effects 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 238000003306 harvesting Methods 0.000 description 2
• DWFOJHYJWHVTMI-UHFFFAOYSA-N hexan-3-yloxy-oxido-oxophosphanium Chemical compound C(CC)C(CC)OP(=O)=O DWFOJHYJWHVTMI-UHFFFAOYSA-N 0.000 description 2
• 229930195733 hydrocarbon Natural products 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 230000001146 hypoxic effect Effects 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 238000007901 in situ hybridization Methods 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 229960003786 inosine Drugs 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 108090000237 interleukin-24 Proteins 0.000 description 2
• 102000003898 interleukin-24 Human genes 0.000 description 2
• 238000001361 intraarterial administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• 230000003907 kidney function Effects 0.000 description 2
• 230000003902 lesion Effects 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 239000004005 microsphere Substances 0.000 description 2
• 238000001823 molecular biology technique Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000009126 molecular therapy Methods 0.000 description 2
• 150000004712 monophosphates Chemical class 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 239000007923 nasal drop Substances 0.000 description 2
• 210000005036 nerve Anatomy 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 201000001119 neuropathy Diseases 0.000 description 2
• 230000007823 neuropathy Effects 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 210000004248 oligodendroglia Anatomy 0.000 description 2
• 102100031691 p53-induced death domain-containing protein 1 Human genes 0.000 description 2
• 208000033808 peripheral neuropathy Diseases 0.000 description 2
• 150000008300 phosphoramidites Chemical class 0.000 description 2
• 231100000614 poison Toxicity 0.000 description 2
• 239000002574 poison Substances 0.000 description 2
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 208000017805 post-transplant lymphoproliferative disease Diseases 0.000 description 2
• 238000004321 preservation Methods 0.000 description 2
• 230000000861 pro-apoptotic effect Effects 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 230000004224 protection Effects 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 230000002685 pulmonary effect Effects 0.000 description 2
• 208000005069 pulmonary fibrosis Diseases 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 108010062302 rac1 GTP Binding Protein Proteins 0.000 description 2
• 230000004264 retinal detachment Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 2
• 229940113082 thymine Drugs 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 230000009529 traumatic brain injury Effects 0.000 description 2
• 150000005691 triesters Chemical class 0.000 description 2
• 230000003612 virological effect Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• JAKVEOCMEMGHGB-YFKPBYRVSA-N (2r)-2-azaniumyl-3-prop-2-ynylsulfanylpropanoate Chemical compound OC(=O)[C@@H](N)CSCC#C JAKVEOCMEMGHGB-YFKPBYRVSA-N 0.000 description 1
• HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• FGODUFHTWYYOOB-UHFFFAOYSA-N 1,3-diaminopropan-2-yl dihydrogen phosphate Chemical compound NCC(CN)OP(O)(O)=O FGODUFHTWYYOOB-UHFFFAOYSA-N 0.000 description 1
• MPCAJMNYNOGXPB-UHFFFAOYSA-N 1,5-anhydrohexitol Chemical class OCC1OCC(O)C(O)C1O MPCAJMNYNOGXPB-UHFFFAOYSA-N 0.000 description 1
• XEVWBBJJPSWWCS-KCRXGDJASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(1-hydroxyethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](C(O)C)O[C@H]1N1C(=O)NC(=O)C=C1 XEVWBBJJPSWWCS-KCRXGDJASA-N 0.000 description 1
• 102100026210 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Human genes 0.000 description 1
• YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
• WYDKPTZGVLTYPG-UHFFFAOYSA-N 2,8-diamino-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(N)N2 WYDKPTZGVLTYPG-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• 102100029829 28S ribosomal protein S29, mitochondrial Human genes 0.000 description 1
• KIWODJBCHRADND-UHFFFAOYSA-N 3-anilino-4-[1-[3-(1-imidazolyl)propyl]-3-indolyl]pyrrole-2,5-dione Chemical compound O=C1NC(=O)C(C=2C3=CC=CC=C3N(CCCN3C=NC=C3)C=2)=C1NC1=CC=CC=C1 KIWODJBCHRADND-UHFFFAOYSA-N 0.000 description 1
• LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• LZINOQJQXIEBNN-UHFFFAOYSA-N 4-hydroxybutyl dihydrogen phosphate Chemical compound OCCCCOP(O)(O)=O LZINOQJQXIEBNN-UHFFFAOYSA-N 0.000 description 1
• OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 1
• ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 1
• 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 1
• LMNPKIOZMGYQIU-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CNC(=O)NC1=O LMNPKIOZMGYQIU-UHFFFAOYSA-N 0.000 description 1
• SVXNJCYYMRMXNM-UHFFFAOYSA-N 5-amino-2h-1,2,4-triazin-3-one Chemical compound NC=1C=NNC(=O)N=1 SVXNJCYYMRMXNM-UHFFFAOYSA-N 0.000 description 1
• OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
• CLGFIVUFZRGQRP-UHFFFAOYSA-N 7,8-dihydro-8-oxoguanine Chemical compound O=C1NC(N)=NC2=C1NC(=O)N2 CLGFIVUFZRGQRP-UHFFFAOYSA-N 0.000 description 1
• PFUVOLUPRFCPMN-UHFFFAOYSA-N 7h-purine-6,8-diamine Chemical compound C1=NC(N)=C2NC(N)=NC2=N1 PFUVOLUPRFCPMN-UHFFFAOYSA-N 0.000 description 1
• RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
• 108010016281 ADP-Ribosylation Factor 1 Proteins 0.000 description 1
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
• 102100034341 ADP-ribosylation factor 1 Human genes 0.000 description 1
• 102100032533 ADP/ATP translocase 1 Human genes 0.000 description 1
• 102000017920 ADRB1 Human genes 0.000 description 1
• 206010065040 AIDS dementia complex Diseases 0.000 description 1
• 206010053227 AIDS retinopathy Diseases 0.000 description 1
• 208000002008 AIDS-Related Lymphoma Diseases 0.000 description 1
• 108060000255 AIM2 Proteins 0.000 description 1
• 101150093961 ANP32A gene Proteins 0.000 description 1
• 102000000872 ATM Human genes 0.000 description 1
• 101150030271 AXIN1 gene Proteins 0.000 description 1
• 206010000050 Abdominal adhesions Diseases 0.000 description 1
• 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 1
• 102100022997 Acidic leucine-rich nuclear phosphoprotein 32 family member A Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 208000004142 Acute Retinal Necrosis Syndrome Diseases 0.000 description 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
• 102100027165 Alpha-2-macroglobulin receptor-associated protein Human genes 0.000 description 1
• 101710126837 Alpha-2-macroglobulin receptor-associated protein Proteins 0.000 description 1
• 241000670727 Amida Species 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 206010002329 Aneurysm Diseases 0.000 description 1
• 102100034613 Annexin A2 Human genes 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 108090000935 Antithrombin III Proteins 0.000 description 1
• 102100022977 Antithrombin-III Human genes 0.000 description 1
• 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 description 1
• 101710127675 Antiviral innate immune response receptor RIG-I Proteins 0.000 description 1
• 208000008286 Aortic Arch Syndromes Diseases 0.000 description 1
• 102100024454 Apoptosis regulatory protein Siva Human genes 0.000 description 1
• 102100029647 Apoptosis-associated speck-like protein containing a CARD Human genes 0.000 description 1
• 102100040124 Apoptosis-inducing factor 1, mitochondrial Human genes 0.000 description 1
• 101710091620 Apoptosis-stimulating of p53 protein 2 Proteins 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 102100035682 Axin-1 Human genes 0.000 description 1
• 102000046016 B-Cell CLL-Lymphoma 10 Human genes 0.000 description 1
• 108700024832 B-Cell CLL-Lymphoma 10 Proteins 0.000 description 1
• 102100035634 B-cell linker protein Human genes 0.000 description 1
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 102100035730 B-cell receptor-associated protein 31 Human genes 0.000 description 1
• 101710113110 B-cell receptor-associated protein 31 Proteins 0.000 description 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
• 101700002522 BARD1 Proteins 0.000 description 1
• 101150074953 BCL10 gene Proteins 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 101150072950 BRCA1 gene Proteins 0.000 description 1
• 102100028048 BRCA1-associated RING domain protein 1 Human genes 0.000 description 1
• 208000009137 Behcet syndrome Diseases 0.000 description 1
• 102100026349 Beta-1,4-galactosyltransferase 1 Human genes 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 102100025401 Breast cancer type 1 susceptibility protein Human genes 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 101150060120 C1qbp gene Proteins 0.000 description 1
• 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 description 1
• 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 1
• 101710100501 CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
• 102000015280 CCAAT-Enhancer-Binding Protein-beta Human genes 0.000 description 1
• 108010064535 CCAAT-Enhancer-Binding Protein-beta Proteins 0.000 description 1
• 102100031168 CCN family member 2 Human genes 0.000 description 1
• 108010017009 CD11b Antigen Proteins 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 102100027221 CD81 antigen Human genes 0.000 description 1
• 102100037904 CD9 antigen Human genes 0.000 description 1
• 108091008038 CHOP Proteins 0.000 description 1
• QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 101100502609 Caenorhabditis elegans fem-1 gene Proteins 0.000 description 1
• 102100033093 Calcium/calmodulin-dependent protein kinase type II subunit alpha Human genes 0.000 description 1
• 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 1
• 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102000004018 Caspase 6 Human genes 0.000 description 1
• 108090000425 Caspase 6 Proteins 0.000 description 1
• 108090000567 Caspase 7 Proteins 0.000 description 1
• 102100024974 Caspase recruitment domain-containing protein 8 Human genes 0.000 description 1
• 102100035904 Caspase-1 Human genes 0.000 description 1
• 108090000426 Caspase-1 Proteins 0.000 description 1
• 102000004068 Caspase-10 Human genes 0.000 description 1
• 108090000572 Caspase-10 Proteins 0.000 description 1
• 102000004066 Caspase-12 Human genes 0.000 description 1
• 108090000570 Caspase-12 Proteins 0.000 description 1
• 102000004958 Caspase-14 Human genes 0.000 description 1
• 108090001132 Caspase-14 Proteins 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 102100025597 Caspase-4 Human genes 0.000 description 1
• 101710090338 Caspase-4 Proteins 0.000 description 1
• 102100038916 Caspase-5 Human genes 0.000 description 1
• 101710090333 Caspase-5 Proteins 0.000 description 1
• 102100038902 Caspase-7 Human genes 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 108090000538 Caspase-8 Proteins 0.000 description 1
• 102000004039 Caspase-9 Human genes 0.000 description 1
• 108090000566 Caspase-9 Proteins 0.000 description 1
• 102100032219 Cathepsin D Human genes 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 102100032137 Cell death activator CIDE-3 Human genes 0.000 description 1
• 102100032141 Cell death activator CIDE-A Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 241000700114 Chinchillidae Species 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 101710082464 Cis-aconitate decarboxylase Proteins 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 102100037078 Complement component 1 Q subcomponent-binding protein, mitochondrial Human genes 0.000 description 1
• 208000034656 Contusions Diseases 0.000 description 1
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
• 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
• 102000000577 Cyclin-Dependent Kinase Inhibitor p27 Human genes 0.000 description 1
• 108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 description 1
• 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 1
• 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 1
• 102100037912 Cyclin-dependent kinase 11A Human genes 0.000 description 1
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
• 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 1
• 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
• 108010072220 Cyclophilin A Proteins 0.000 description 1
• 102100030497 Cytochrome c Human genes 0.000 description 1
• 108010075031 Cytochromes c Proteins 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 102100032620 Cytotoxic granule associated RNA binding protein TIA1 Human genes 0.000 description 1
• 101150077031 DAXX gene Proteins 0.000 description 1
• 102100029145 DNA damage-inducible transcript 3 protein Human genes 0.000 description 1
• 102100025900 DNA damage-inducible transcript 4-like protein Human genes 0.000 description 1
• 101710147299 DNA fragmentation factor subunit beta Proteins 0.000 description 1
• 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
• 102100024762 DNA-binding death effector domain-containing protein 2 Human genes 0.000 description 1
• 101150078308 DOK1 gene Proteins 0.000 description 1
• 101100174544 Danio rerio foxo1a gene Proteins 0.000 description 1
• 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
• 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
• 101100411708 Danio rerio rarga gene Proteins 0.000 description 1
• 101100202237 Danio rerio rxrab gene Proteins 0.000 description 1
• 101100309320 Danio rerio rxrga gene Proteins 0.000 description 1
• 102100028559 Death domain-associated protein 6 Human genes 0.000 description 1
• 102100038713 Death domain-containing protein CRADD Human genes 0.000 description 1
• 102100024693 Death effector domain-containing protein Human genes 0.000 description 1
• 102100032501 Death-inducer obliterator 1 Human genes 0.000 description 1
• 101710081796 Death-inducer obliterator 1 Proteins 0.000 description 1
• 108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 description 1
• 206010012688 Diabetic retinal oedema Diseases 0.000 description 1
• 206010056340 Diabetic ulcer Diseases 0.000 description 1
• 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 description 1
• 101710101225 Diablo IAP-binding mitochondrial protein Proteins 0.000 description 1
• 101710099518 Dickkopf-related protein 1 Proteins 0.000 description 1
• 102100030074 Dickkopf-related protein 1 Human genes 0.000 description 1
• 101000836492 Dictyostelium discoideum ALG-2 interacting protein X Proteins 0.000 description 1
• 101000617550 Dictyostelium discoideum Presenilin-A Proteins 0.000 description 1
• 101100226017 Dictyostelium discoideum repD gene Proteins 0.000 description 1
• 102100034581 Dihydroorotase Human genes 0.000 description 1
• 102100028572 Disabled homolog 2 Human genes 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 108050003188 Disks large-associated protein 1 Proteins 0.000 description 1
• 102100031250 Disks large-associated protein 1 Human genes 0.000 description 1
• 108050003186 Disks large-associated protein 3 Proteins 0.000 description 1
• 102100039059 Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Human genes 0.000 description 1
• 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 1
• 102100029791 Double-stranded RNA-specific adenosine deaminase Human genes 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101100334582 Drosophila melanogaster Fem-1 gene Proteins 0.000 description 1
• 101100181139 Drosophila melanogaster Pkcdelta gene Proteins 0.000 description 1
• 102100029638 Dual serine/threonine and tyrosine protein kinase Human genes 0.000 description 1
• 108010036466 E2F2 Transcription Factor Proteins 0.000 description 1
• 102100021838 E3 ubiquitin-protein ligase SIAH1 Human genes 0.000 description 1
• 102100031748 E3 ubiquitin-protein ligase SIAH2 Human genes 0.000 description 1
• 101710128187 E3 ubiquitin-protein ligase Siah1 Proteins 0.000 description 1
• 101710128185 E3 ubiquitin-protein ligase Siah2 Proteins 0.000 description 1
• 102100024816 E3 ubiquitin-protein ligase TRAF7 Human genes 0.000 description 1
• 102100032274 E3 ubiquitin-protein ligase TRAIP Human genes 0.000 description 1
• 102100029501 E3 ubiquitin-protein ligase TRIM35 Human genes 0.000 description 1
• 101150059401 EGR2 gene Proteins 0.000 description 1
• 101150000195 EGR3 gene Proteins 0.000 description 1
• 101150105460 ERCC2 gene Proteins 0.000 description 1
• 208000019878 Eales disease Diseases 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 208000005189 Embolism Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• 102100032670 Endophilin-B1 Human genes 0.000 description 1
• 102100031702 Endoplasmic reticulum membrane sensor NFE2L1 Human genes 0.000 description 1
• 102100030013 Endoribonuclease Human genes 0.000 description 1
• 102100021579 Enhancer of filamentation 1 Human genes 0.000 description 1
• 108010055196 EphA2 Receptor Proteins 0.000 description 1
• 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 1
• 244000070010 Erythrina variegata Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 101000768061 Escherichia phage P1 Antirepressor protein 1 Proteins 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 101150031329 Ets1 gene Proteins 0.000 description 1
• 208000035620 Eye penetration Diseases 0.000 description 1
• 102100026693 FAS-associated death domain protein Human genes 0.000 description 1
• 102100027279 FAS-associated factor 1 Human genes 0.000 description 1
• 101150106966 FOXO1 gene Proteins 0.000 description 1
• 101150113567 FZD1 gene Proteins 0.000 description 1
• 102100021056 Ferroptosis suppressor protein 1 Human genes 0.000 description 1
• 101710204931 Ferroptosis suppressor protein 1 Proteins 0.000 description 1
• 102100037680 Fibroblast growth factor 8 Human genes 0.000 description 1
• 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
• 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010016717 Fistula Diseases 0.000 description 1
• 102100035421 Forkhead box protein O3 Human genes 0.000 description 1
• 208000024412 Friedreich ataxia Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108010001498 Galectin 1 Proteins 0.000 description 1
• 102000000802 Galectin 3 Human genes 0.000 description 1
• 108010001517 Galectin 3 Proteins 0.000 description 1
• 102100021736 Galectin-1 Human genes 0.000 description 1
• 102000044465 Galectin-7 Human genes 0.000 description 1
• 102100031351 Galectin-9 Human genes 0.000 description 1
• 101710121810 Galectin-9 Proteins 0.000 description 1
• 102100039928 Gamma-interferon-inducible protein 16 Human genes 0.000 description 1
• 208000003098 Ganglion Cysts Diseases 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 102100031885 General transcription and DNA repair factor IIH helicase subunit XPB Human genes 0.000 description 1
• 102100035184 General transcription and DNA repair factor IIH helicase subunit XPD Human genes 0.000 description 1
• 208000007465 Giant cell arteritis Diseases 0.000 description 1
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• 101150113453 Gsk3a gene Proteins 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 108010058607 HLA-B Antigens Proteins 0.000 description 1
• 206010071252 Haemorrhagic vasculitis Diseases 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• 101800003471 Helicase Proteins 0.000 description 1
• 101800000791 Hemagglutinin-esterase-fusion glycoprotein chain 1 Proteins 0.000 description 1
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
• 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 1
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 1
• 108091021225 Heterogeneous Nuclear Ribonucleoprotein D0 Proteins 0.000 description 1
• 102100022893 Histone acetyltransferase KAT5 Human genes 0.000 description 1
• 101710116149 Histone acetyltransferase KAT5 Proteins 0.000 description 1
• 241000228402 Histoplasma Species 0.000 description 1
• 101000691589 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Proteins 0.000 description 1
• 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
• 101000796932 Homo sapiens ADP/ATP translocase 1 Proteins 0.000 description 1
• 101000836540 Homo sapiens Aldo-keto reductase family 1 member B1 Proteins 0.000 description 1
• 101000891547 Homo sapiens Alpha-1,3/1,6-mannosyltransferase ALG2 Proteins 0.000 description 1
• 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 1
• 101000688963 Homo sapiens Apoptosis regulatory protein Siva Proteins 0.000 description 1
• 101000890622 Homo sapiens Apoptosis-inducing factor 1, mitochondrial Proteins 0.000 description 1
• 101000803266 Homo sapiens B-cell linker protein Proteins 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 101000892264 Homo sapiens Beta-1 adrenergic receptor Proteins 0.000 description 1
• 101000766145 Homo sapiens Beta-1,4-galactosyltransferase 1 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 description 1
• 101100168465 Homo sapiens CAPNS1 gene Proteins 0.000 description 1
• 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
• 101000944249 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit alpha Proteins 0.000 description 1
• 101000981093 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 1 Proteins 0.000 description 1
• 101000761247 Homo sapiens Caspase recruitment domain-containing protein 8 Proteins 0.000 description 1
• 101000869010 Homo sapiens Cathepsin D Proteins 0.000 description 1
• 101000775558 Homo sapiens Cell death activator CIDE-3 Proteins 0.000 description 1
• 101000775570 Homo sapiens Cell death activator CIDE-A Proteins 0.000 description 1
• 101000642971 Homo sapiens Cohesin subunit SA-1 Proteins 0.000 description 1
• 101000856395 Homo sapiens Cullin-9 Proteins 0.000 description 1
• 101000897488 Homo sapiens Cyclin-D1-binding protein 1 Proteins 0.000 description 1
• 101000738403 Homo sapiens Cyclin-dependent kinase 11A Proteins 0.000 description 1
• 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101000654853 Homo sapiens Cytotoxic granule associated RNA binding protein TIA1 Proteins 0.000 description 1
• 101000720858 Homo sapiens DNA damage-inducible transcript 4-like protein Proteins 0.000 description 1
• 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
• 101000830366 Homo sapiens DNA-binding death effector domain-containing protein 2 Proteins 0.000 description 1
• 101000957914 Homo sapiens Death domain-containing protein CRADD Proteins 0.000 description 1
• 101000830359 Homo sapiens Death effector domain-containing protein Proteins 0.000 description 1
• 101000915391 Homo sapiens Disabled homolog 2 Proteins 0.000 description 1
• 101000958975 Homo sapiens Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Proteins 0.000 description 1
• 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 1
• 101000865408 Homo sapiens Double-stranded RNA-specific adenosine deaminase Proteins 0.000 description 1
• 101000865739 Homo sapiens Dual serine/threonine and tyrosine protein kinase Proteins 0.000 description 1
• 101000837060 Homo sapiens E3 ubiquitin-protein ligase SH3RF1 Proteins 0.000 description 1
• 101000830899 Homo sapiens E3 ubiquitin-protein ligase TRAF7 Proteins 0.000 description 1
• 101000798079 Homo sapiens E3 ubiquitin-protein ligase TRAIP Proteins 0.000 description 1
• 101000634987 Homo sapiens E3 ubiquitin-protein ligase TRIM35 Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101000654648 Homo sapiens Endophilin-B1 Proteins 0.000 description 1
• 101000588298 Homo sapiens Endoplasmic reticulum membrane sensor NFE2L1 Proteins 0.000 description 1
• 101001010783 Homo sapiens Endoribonuclease Proteins 0.000 description 1
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 1
• 101000914654 Homo sapiens FAS-associated factor 1 Proteins 0.000 description 1
• 101001027382 Homo sapiens Fibroblast growth factor 8 Proteins 0.000 description 1
• 101000877727 Homo sapiens Forkhead box protein O1 Proteins 0.000 description 1
• 101000877681 Homo sapiens Forkhead box protein O3 Proteins 0.000 description 1
• 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 1
• 101000960209 Homo sapiens Gamma-interferon-inducible protein 16 Proteins 0.000 description 1
• 101000920748 Homo sapiens General transcription and DNA repair factor IIH helicase subunit XPB Proteins 0.000 description 1
• 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 1
• 101001017535 Homo sapiens Heterogeneous nuclear ribonucleoprotein D0 Proteins 0.000 description 1
• 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 1
• 101001021527 Homo sapiens Huntingtin-interacting protein 1 Proteins 0.000 description 1
• 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 1
• 101001053710 Homo sapiens Inhibitor of growth protein 1 Proteins 0.000 description 1
• 101001011989 Homo sapiens Inositol hexakisphosphate kinase 2 Proteins 0.000 description 1
• 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
• 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 description 1
• 101001011382 Homo sapiens Interferon regulatory factor 3 Proteins 0.000 description 1
• 101001011441 Homo sapiens Interferon regulatory factor 4 Proteins 0.000 description 1
• 101001032341 Homo sapiens Interferon regulatory factor 9 Proteins 0.000 description 1
• 101001128393 Homo sapiens Interferon-induced GTP-binding protein Mx1 Proteins 0.000 description 1
• 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 1
• 101001006892 Homo sapiens Krueppel-like factor 10 Proteins 0.000 description 1
• 101001017828 Homo sapiens Leucine-rich repeat flightless-interacting protein 1 Proteins 0.000 description 1
• 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
• 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
• 101000581326 Homo sapiens Mediator of DNA damage checkpoint protein 1 Proteins 0.000 description 1
• 101001057158 Homo sapiens Melanoma-associated antigen D1 Proteins 0.000 description 1
• 101000880398 Homo sapiens Metalloreductase STEAP3 Proteins 0.000 description 1
• 101000880402 Homo sapiens Metalloreductase STEAP4 Proteins 0.000 description 1
• 101000615492 Homo sapiens Methyl-CpG-binding domain protein 4 Proteins 0.000 description 1
• 101000958409 Homo sapiens Mitogen-activated protein kinase kinase kinase 10 Proteins 0.000 description 1
• 101001005602 Homo sapiens Mitogen-activated protein kinase kinase kinase 11 Proteins 0.000 description 1
• 101001018196 Homo sapiens Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 1
• 101001055092 Homo sapiens Mitogen-activated protein kinase kinase kinase 7 Proteins 0.000 description 1
• 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
• 101001055085 Homo sapiens Mitogen-activated protein kinase kinase kinase 9 Proteins 0.000 description 1
• 101001059991 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 1 Proteins 0.000 description 1
• 101001059990 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 2 Proteins 0.000 description 1
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
• 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 description 1
• 101001109463 Homo sapiens NACHT, LRR and PYD domains-containing protein 1 Proteins 0.000 description 1
• 101000636665 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 Proteins 0.000 description 1
• 101000603359 Homo sapiens NADPH oxidase organizer 1 Proteins 0.000 description 1
• 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
• 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 description 1
• 101001128694 Homo sapiens Neuroendocrine convertase 1 Proteins 0.000 description 1
• 101000979249 Homo sapiens Neuromodulin Proteins 0.000 description 1
• 101000785705 Homo sapiens Neurotrophin receptor-interacting factor homolog Proteins 0.000 description 1
• 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 description 1
• 101001109689 Homo sapiens Nuclear receptor subfamily 4 group A member 3 Proteins 0.000 description 1
• 101000577547 Homo sapiens Nuclear respiratory factor 1 Proteins 0.000 description 1
• 101000992283 Homo sapiens Optineurin Proteins 0.000 description 1
• 101001098175 Homo sapiens P2X purinoceptor 7 Proteins 0.000 description 1
• 101100354855 Homo sapiens PYDC1 gene Proteins 0.000 description 1
• 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 description 1
• 101000616502 Homo sapiens Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 Proteins 0.000 description 1
• 101000983161 Homo sapiens Phospholipase A2, membrane associated Proteins 0.000 description 1
• 101000583692 Homo sapiens Pleckstrin homology-like domain family A member 1 Proteins 0.000 description 1
• 101000586618 Homo sapiens Poliovirus receptor Proteins 0.000 description 1
• 101000589450 Homo sapiens Poly(ADP-ribose) glycohydrolase Proteins 0.000 description 1
• 101000735365 Homo sapiens Poly(rC)-binding protein 4 Proteins 0.000 description 1
• 101001134621 Homo sapiens Programmed cell death 6-interacting protein Proteins 0.000 description 1
• 101000959489 Homo sapiens Protein AF-9 Proteins 0.000 description 1
• 101000933252 Homo sapiens Protein BEX3 Proteins 0.000 description 1
• 101000933601 Homo sapiens Protein BTG1 Proteins 0.000 description 1
• 101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
• 101000620365 Homo sapiens Protein TMEPAI Proteins 0.000 description 1
• 101000735463 Homo sapiens Protein mono-ADP-ribosyltransferase PARP4 Proteins 0.000 description 1
• 101000611643 Homo sapiens Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
• 101001092982 Homo sapiens Protein salvador homolog 1 Proteins 0.000 description 1
• 101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 description 1
• 101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 description 1
• 101000848502 Homo sapiens RNA polymerase II-associated protein 3 Proteins 0.000 description 1
• 101000945096 Homo sapiens Ribosomal protein S6 kinase alpha-5 Proteins 0.000 description 1
• 101000694550 Homo sapiens RuvB-like 1 Proteins 0.000 description 1
• 101000688582 Homo sapiens SH3 domain-containing kinase-binding protein 1 Proteins 0.000 description 1
• 101100150143 Homo sapiens SPRR3 gene Proteins 0.000 description 1
• 101000652133 Homo sapiens STE20-like serine/threonine-protein kinase Proteins 0.000 description 1
• 101000864743 Homo sapiens Secreted frizzled-related protein 1 Proteins 0.000 description 1
• 101000867413 Homo sapiens Segment polarity protein dishevelled homolog DVL-1 Proteins 0.000 description 1
• 101000632270 Homo sapiens Semaphorin-3B Proteins 0.000 description 1
• 101000785063 Homo sapiens Serine-protein kinase ATM Proteins 0.000 description 1
• 101000661821 Homo sapiens Serine/threonine-protein kinase 17A Proteins 0.000 description 1
• 101000661819 Homo sapiens Serine/threonine-protein kinase 17B Proteins 0.000 description 1
• 101000880431 Homo sapiens Serine/threonine-protein kinase 4 Proteins 0.000 description 1
• 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
• 101001047642 Homo sapiens Serine/threonine-protein kinase LATS1 Proteins 0.000 description 1
• 101000739905 Homo sapiens Sestrin-2 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 description 1
• 101000701815 Homo sapiens Spermidine synthase Proteins 0.000 description 1
• 101000785978 Homo sapiens Sphingomyelin phosphodiesterase Proteins 0.000 description 1
• 101000979912 Homo sapiens Sphingomyelin phosphodiesterase 2 Proteins 0.000 description 1
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
• 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 1
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 1
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000835082 Homo sapiens TCF3 fusion partner Proteins 0.000 description 1
• 101000800099 Homo sapiens THO complex subunit 1 Proteins 0.000 description 1
• 101000595548 Homo sapiens TIR domain-containing adapter molecule 1 Proteins 0.000 description 1
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
• 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
• 101000665590 Homo sapiens Tax1-binding protein 1 Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
• 101000976959 Homo sapiens Transcription factor 4 Proteins 0.000 description 1
• 101000596771 Homo sapiens Transcription factor 7-like 2 Proteins 0.000 description 1
• 101000757378 Homo sapiens Transcription factor AP-2-alpha Proteins 0.000 description 1
• 101000904152 Homo sapiens Transcription factor E2F1 Proteins 0.000 description 1
• 101000904150 Homo sapiens Transcription factor E2F3 Proteins 0.000 description 1
• 101000723938 Homo sapiens Transcription factor HIVEP3 Proteins 0.000 description 1
• 101000755529 Homo sapiens Transforming protein RhoA Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
• 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 description 1
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 1
• 101000798130 Homo sapiens Tumor necrosis factor receptor superfamily member 11B Proteins 0.000 description 1
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
• 101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 description 1
• 101000679921 Homo sapiens Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 1
• 101000679907 Homo sapiens Tumor necrosis factor receptor superfamily member 27 Proteins 0.000 description 1
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 101000920026 Homo sapiens Tumor necrosis factor receptor superfamily member EDAR Proteins 0.000 description 1
• 101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 1
• 101000823271 Homo sapiens Tyrosine-protein kinase ABL2 Proteins 0.000 description 1
• 101000587313 Homo sapiens Tyrosine-protein kinase Srms Proteins 0.000 description 1
• 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 description 1
• 101000760439 Homo sapiens UNC5C-like protein Proteins 0.000 description 1
• 101000662056 Homo sapiens Ubiquitin D Proteins 0.000 description 1
• 101000723423 Homo sapiens Ubiquitin thioesterase ZRANB1 Proteins 0.000 description 1
• 101000743798 Homo sapiens Zinc finger HIT domain-containing protein 1 Proteins 0.000 description 1
• 101000723893 Homo sapiens Zinc finger matrin-type protein 3 Proteins 0.000 description 1
• 101000759255 Homo sapiens Zinc finger protein 148 Proteins 0.000 description 1
• 101000723915 Homo sapiens Zinc finger protein 319 Proteins 0.000 description 1
• 101000723920 Homo sapiens Zinc finger protein 40 Proteins 0.000 description 1
• 101000782276 Homo sapiens Zinc finger protein 622 Proteins 0.000 description 1
• 101001127470 Homo sapiens p53 apoptosis effector related to PMP-22 Proteins 0.000 description 1
• 101000851815 Homo sapiens p53-regulated apoptosis-inducing protein 1 Proteins 0.000 description 1
• 101150069138 HtrA2 gene Proteins 0.000 description 1
• 102100035957 Huntingtin-interacting protein 1 Human genes 0.000 description 1
• 206010051151 Hyperviscosity syndrome Diseases 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 1
• 108060006678 I-kappa-B kinase Proteins 0.000 description 1
• 102000001284 I-kappa-B kinase Human genes 0.000 description 1
• 241000571697 Icarus Species 0.000 description 1
• 208000031814 IgA Vasculitis Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100024065 Inhibitor of growth protein 1 Human genes 0.000 description 1
• 102100024067 Inhibitor of growth protein 2 Human genes 0.000 description 1
• 108050006209 Inhibitor of growth protein 2 Proteins 0.000 description 1
• 102100030212 Inositol hexakisphosphate kinase 2 Human genes 0.000 description 1
• 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 description 1
• 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 102100022337 Integrin alpha-V Human genes 0.000 description 1
• 102100025390 Integrin beta-2 Human genes 0.000 description 1
• 102100032999 Integrin beta-3 Human genes 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 102100036981 Interferon regulatory factor 1 Human genes 0.000 description 1
• 102100029843 Interferon regulatory factor 3 Human genes 0.000 description 1
• 102100030126 Interferon regulatory factor 4 Human genes 0.000 description 1
• 102100038251 Interferon regulatory factor 9 Human genes 0.000 description 1
• 102100031802 Interferon-induced GTP-binding protein Mx1 Human genes 0.000 description 1
• 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 1
• 101710089751 Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 1
• 102100024064 Interferon-inducible protein AIM2 Human genes 0.000 description 1
• 102000003777 Interleukin-1 beta Human genes 0.000 description 1
• 108090000193 Interleukin-1 beta Proteins 0.000 description 1
• 102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 description 1
• 101710199015 Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102100039879 Interleukin-19 Human genes 0.000 description 1
• 108050009288 Interleukin-19 Proteins 0.000 description 1
• 102000004125 Interleukin-1alpha Human genes 0.000 description 1
• 108010082786 Interleukin-1alpha Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102000000588 Interleukin-2 Human genes 0.000 description 1
• 102100030703 Interleukin-22 Human genes 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102100039897 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 102100021592 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 206010022941 Iridocyclitis Diseases 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 1
• 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 102100027798 Krueppel-like factor 10 Human genes 0.000 description 1
• 101150028321 Lck gene Proteins 0.000 description 1
• 208000018142 Leiomyosarcoma Diseases 0.000 description 1
• 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 208000019693 Lung disease Diseases 0.000 description 1
• 206010025312 Lymphoma AIDS related Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100035304 Lymphotactin Human genes 0.000 description 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
• 102100026894 Lymphotoxin-beta Human genes 0.000 description 1
• 108090000362 Lymphotoxin-beta Proteins 0.000 description 1
• 108010075654 MAP Kinase Kinase Kinase 1 Proteins 0.000 description 1
• 108700012928 MAPK14 Proteins 0.000 description 1
• 102000034655 MIF Human genes 0.000 description 1
• 108060004872 MIF Proteins 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 description 1
• 101150003941 Mapk14 gene Proteins 0.000 description 1
• 102100027643 Mediator of DNA damage checkpoint protein 1 Human genes 0.000 description 1
• 206010027145 Melanocytic naevus Diseases 0.000 description 1
• 102100027247 Melanoma-associated antigen D1 Human genes 0.000 description 1
• 108010060408 Member 25 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 102100037653 Metalloreductase STEAP3 Human genes 0.000 description 1
• 102100037654 Metalloreductase STEAP4 Human genes 0.000 description 1
• 102100021290 Methyl-CpG-binding domain protein 4 Human genes 0.000 description 1
• 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 1
• 102100030157 Microphthalmia-associated transcription factor Human genes 0.000 description 1
• 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
• 102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 description 1
• 102100038243 Mitogen-activated protein kinase kinase kinase 10 Human genes 0.000 description 1
• 102100025207 Mitogen-activated protein kinase kinase kinase 11 Human genes 0.000 description 1
• 102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 description 1
• 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 1
• 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 1
• 102100026909 Mitogen-activated protein kinase kinase kinase 9 Human genes 0.000 description 1
• 102100028199 Mitogen-activated protein kinase kinase kinase kinase 1 Human genes 0.000 description 1
• 102100028192 Mitogen-activated protein kinase kinase kinase kinase 2 Human genes 0.000 description 1
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
• 101150118570 Msx2 gene Proteins 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 101000856426 Mus musculus Cullin-7 Proteins 0.000 description 1
• 101100473971 Mus musculus Pdcd11 gene Proteins 0.000 description 1
• 101100046559 Mus musculus Tnfrsf12a gene Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 description 1
• 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• 206010028570 Myelopathy Diseases 0.000 description 1
• 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 1
• 101710156256 Myosin phosphatase Rho-interacting protein Proteins 0.000 description 1
• 102100022698 NACHT, LRR and PYD domains-containing protein 1 Human genes 0.000 description 1
• 102100031924 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 Human genes 0.000 description 1
• 108090000424 NADPH Oxidase 1 Proteins 0.000 description 1
• 102000004019 NADPH Oxidase 1 Human genes 0.000 description 1
• 102100039033 NADPH oxidase organizer 1 Human genes 0.000 description 1
• 102100027673 NCK-interacting protein with SH3 domain Human genes 0.000 description 1
• 102100023435 NLR family CARD domain-containing protein 4 Human genes 0.000 description 1
• 101710182264 NLR family CARD domain-containing protein 4 Proteins 0.000 description 1
• 101150111783 NTRK1 gene Proteins 0.000 description 1
• 101150117329 NTRK3 gene Proteins 0.000 description 1
• 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 1
• 102000003729 Neprilysin Human genes 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 102000008730 Nestin Human genes 0.000 description 1
• 108010088225 Nestin Proteins 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 102100023206 Neuromodulin Human genes 0.000 description 1
• 108090000189 Neuropeptides Proteins 0.000 description 1
• 102000003797 Neuropeptides Human genes 0.000 description 1
• 102100026325 Neurotrophin receptor-interacting factor homolog Human genes 0.000 description 1
• 208000007256 Nevus Diseases 0.000 description 1
• 101150114527 Nkx2-5 gene Proteins 0.000 description 1
• 108010041199 Nogo Receptor 1 Proteins 0.000 description 1
• 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 1
• 102100022673 Nuclear receptor subfamily 4 group A member 3 Human genes 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 102100031822 Optineurin Human genes 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• SCFZPNMWAYHION-UHFFFAOYSA-N P(=O)(OCCCCCCN)(O)O.P(=O)(OCCCN)(O)O Chemical compound P(=O)(OCCCCCCN)(O)O.P(=O)(OCCCN)(O)O SCFZPNMWAYHION-UHFFFAOYSA-N 0.000 description 1
• 102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
• 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
• 101150094159 PU1 gene Proteins 0.000 description 1
• 101150010895 PYC1 gene Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
• 101710111198 Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 1
• 206010034665 Peritoneal fibrosis Diseases 0.000 description 1
• 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 1
• 102100021797 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 Human genes 0.000 description 1
• 102100026831 Phospholipase A2, membrane associated Human genes 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 102100030887 Pleckstrin homology-like domain family A member 1 Human genes 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 102100029740 Poliovirus receptor Human genes 0.000 description 1
• 102100032347 Poly(ADP-ribose) glycohydrolase Human genes 0.000 description 1
• 102100034956 Poly(rC)-binding protein 4 Human genes 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 102100025067 Potassium voltage-gated channel subfamily H member 4 Human genes 0.000 description 1
• 101710163352 Potassium voltage-gated channel subfamily H member 4 Proteins 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 208000024777 Prion disease Diseases 0.000 description 1
• 101710145525 Probable cinnamyl alcohol dehydrogenase Proteins 0.000 description 1
• 102100034785 Programmed cell death protein 6 Human genes 0.000 description 1
• 102100034694 Programmed cell death protein 7 Human genes 0.000 description 1
• 101710089366 Programmed cell death protein 7 Proteins 0.000 description 1
• 108010057464 Prolactin Proteins 0.000 description 1
• 102000003946 Prolactin Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 102100039686 Protein AF-9 Human genes 0.000 description 1
• 102100025955 Protein BEX3 Human genes 0.000 description 1
• 102100026036 Protein BTG1 Human genes 0.000 description 1
• 108010078137 Protein Kinase C-epsilon Proteins 0.000 description 1
• 102000014458 Protein Kinase C-epsilon Human genes 0.000 description 1
• 108010015499 Protein Kinase C-theta Proteins 0.000 description 1
• 102000001892 Protein Kinase C-theta Human genes 0.000 description 1
• 102100026375 Protein PML Human genes 0.000 description 1
• 102100022429 Protein TMEPAI Human genes 0.000 description 1
• 102100027584 Protein c-Fos Human genes 0.000 description 1
• 102100024924 Protein kinase C alpha type Human genes 0.000 description 1
• 101710109947 Protein kinase C alpha type Proteins 0.000 description 1
• 102100034931 Protein mono-ADP-ribosyltransferase PARP4 Human genes 0.000 description 1
• 102100040714 Protein phosphatase 1 regulatory subunit 15A Human genes 0.000 description 1
• 102100036193 Protein salvador homolog 1 Human genes 0.000 description 1
• 102100023710 Proteinase-activated receptor 4 Human genes 0.000 description 1
• 101710121439 Proteinase-activated receptor 4 Proteins 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• 108010089507 Proto-Oncogene Proteins c-maf Proteins 0.000 description 1
• 102000007987 Proto-Oncogene Proteins c-maf Human genes 0.000 description 1
• 102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 description 1
• 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 1
• 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 1
• 102100039892 Pyrin domain-containing protein 1 Human genes 0.000 description 1
• 108010025832 RANK Ligand Proteins 0.000 description 1
• 102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 description 1
• 102100034617 RNA polymerase II-associated protein 3 Human genes 0.000 description 1
• 102100022419 RPA-interacting protein Human genes 0.000 description 1
• 101150050070 RXRA gene Proteins 0.000 description 1
• 206010064714 Radiation retinopathy Diseases 0.000 description 1
• 241000269435 Rana <genus> Species 0.000 description 1
• 101150066717 Rara gene Proteins 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 101100501785 Rattus norvegicus Esr2 gene Proteins 0.000 description 1
• 108010079933 Receptor-Interacting Protein Serine-Threonine Kinase 2 Proteins 0.000 description 1
• 102100022502 Receptor-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 1
• 102100033729 Receptor-interacting serine/threonine-protein kinase 3 Human genes 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 102100037415 Regulator of G-protein signaling 3 Human genes 0.000 description 1
• 101710140411 Regulator of G-protein signaling 3 Proteins 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 102100029826 Reticulon-4 receptor Human genes 0.000 description 1
• 201000007527 Retinal artery occlusion Diseases 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 206010038926 Retinopathy hypertensive Diseases 0.000 description 1
• 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
• 206010038935 Retinopathy sickle cell Diseases 0.000 description 1
• 101150054980 Rhob gene Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102100033645 Ribosomal protein S6 kinase alpha-5 Human genes 0.000 description 1
• 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 1
• 102100027160 RuvB-like 1 Human genes 0.000 description 1
• 102100024244 SH3 domain-containing kinase-binding protein 1 Human genes 0.000 description 1
• 102100022340 SHC-transforming protein 1 Human genes 0.000 description 1
• 108091006296 SLC2A1 Proteins 0.000 description 1
• 108091006299 SLC2A2 Proteins 0.000 description 1
• 108091006277 SLC5A1 Proteins 0.000 description 1
• 101150009018 SPI-1 gene Proteins 0.000 description 1
• 101100030133 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SEC53 gene Proteins 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 102100030058 Secreted frizzled-related protein 1 Human genes 0.000 description 1
• 102100032758 Segment polarity protein dishevelled homolog DVL-1 Human genes 0.000 description 1
• 102100027974 Semaphorin-3A Human genes 0.000 description 1
• 108010090319 Semaphorin-3A Proteins 0.000 description 1
• 102100027979 Semaphorin-3B Human genes 0.000 description 1
• 101710146118 Serine protease HTRA2, mitochondrial Proteins 0.000 description 1
• 102100020824 Serine-protein kinase ATM Human genes 0.000 description 1
• 102100037955 Serine/threonine-protein kinase 17A Human genes 0.000 description 1
• 102100037959 Serine/threonine-protein kinase 17B Human genes 0.000 description 1
• 102100037629 Serine/threonine-protein kinase 4 Human genes 0.000 description 1
• 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 1
• 102100024031 Serine/threonine-protein kinase LATS1 Human genes 0.000 description 1
• 102100040293 Serine/threonine-protein kinase LMTK1 Human genes 0.000 description 1
• 101710118516 Serine/threonine-protein kinase LMTK1 Proteins 0.000 description 1
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 1
• 102100037576 Sestrin-2 Human genes 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 102100038979 Small proline-rich protein 3 Human genes 0.000 description 1
• 101150045565 Socs1 gene Proteins 0.000 description 1
• 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 description 1
• 102100023536 Solute carrier family 2, facilitated glucose transporter member 1 Human genes 0.000 description 1
• 102100023537 Solute carrier family 2, facilitated glucose transporter member 2 Human genes 0.000 description 1
• 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 1
• 101710184713 Sorbitol dehydrogenase Proteins 0.000 description 1
• 102100026263 Sphingomyelin phosphodiesterase Human genes 0.000 description 1
• 102100024550 Sphingomyelin phosphodiesterase 2 Human genes 0.000 description 1
• 108091027076 Spiegelmer Proteins 0.000 description 1
• 201000010829 Spina bifida Diseases 0.000 description 1
• 208000006097 Spinal Dysraphism Diseases 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 108010087999 Steryl-Sulfatase Proteins 0.000 description 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
• 101100342402 Synechocystis sp. (strain PCC 6803 / Kazusa) prk gene Proteins 0.000 description 1
• 208000005400 Synovial Cyst Diseases 0.000 description 1
• 208000004732 Systemic Vasculitis Diseases 0.000 description 1
• 108010014480 T-box transcription factor 5 Proteins 0.000 description 1
• 102100024755 T-box transcription factor TBX5 Human genes 0.000 description 1
• 102100027208 T-cell antigen CD7 Human genes 0.000 description 1
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 1
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 102100026140 TCF3 fusion partner Human genes 0.000 description 1
• 102100033489 THO complex subunit 1 Human genes 0.000 description 1
• 101150052863 THY1 gene Proteins 0.000 description 1
• 102100036073 TIR domain-containing adapter molecule 1 Human genes 0.000 description 1
• 102000004399 TNF receptor-associated factor 3 Human genes 0.000 description 1
• 108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 1
• 108090000008 TNF receptor-associated factor 4 Proteins 0.000 description 1
• 102000003715 TNF receptor-associated factor 4 Human genes 0.000 description 1
• 102000003714 TNF receptor-associated factor 6 Human genes 0.000 description 1
• 108090000009 TNF receptor-associated factor 6 Proteins 0.000 description 1
• 108700012411 TNFSF10 Proteins 0.000 description 1
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
• 102000003615 TRPM2 Human genes 0.000 description 1
• 101150095096 TRPM2 gene Proteins 0.000 description 1
• 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• 102100038193 Tax1-binding protein 1 Human genes 0.000 description 1
• 108010033711 Telomeric Repeat Binding Protein 1 Proteins 0.000 description 1
• 102100036497 Telomeric repeat-binding factor 1 Human genes 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 208000033781 Thyroid carcinoma Diseases 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
• 102100023489 Transcription factor 4 Human genes 0.000 description 1
• 102100022972 Transcription factor AP-2-alpha Human genes 0.000 description 1
• 102100024026 Transcription factor E2F1 Human genes 0.000 description 1
• 102100024024 Transcription factor E2F2 Human genes 0.000 description 1
• 102100024027 Transcription factor E2F3 Human genes 0.000 description 1
• 102100028336 Transcription factor HIVEP3 Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 108010091356 Tumor Protein p73 Proteins 0.000 description 1
• 102000018252 Tumor Protein p73 Human genes 0.000 description 1
• 102000000504 Tumor Suppressor p53-Binding Protein 1 Human genes 0.000 description 1
• 108010041385 Tumor Suppressor p53-Binding Protein 1 Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 1
• 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 description 1
• 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 description 1
• 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 1
• 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 1
• 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 1
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
• 102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 description 1
• 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 1
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 1
• 102100022202 Tumor necrosis factor receptor superfamily member 27 Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 102100030810 Tumor necrosis factor receptor superfamily member EDAR Human genes 0.000 description 1
• 102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 1
• 102100027224 Tumor protein p53-inducible nuclear protein 1 Human genes 0.000 description 1
• 108050003317 Tumor protein p53-inducible nuclear protein 1 Proteins 0.000 description 1
• 102100022651 Tyrosine-protein kinase ABL2 Human genes 0.000 description 1
• 102100029654 Tyrosine-protein kinase Srms Human genes 0.000 description 1
• 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 1
• 102100024742 UNC5C-like protein Human genes 0.000 description 1
• 101150020913 USP7 gene Proteins 0.000 description 1
• 101710138219 Ubiquitin D Proteins 0.000 description 1
• 102100021013 Ubiquitin carboxyl-terminal hydrolase 7 Human genes 0.000 description 1
• 102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 1
• 102100027846 Ubiquitin thioesterase ZRANB1 Human genes 0.000 description 1
• 108700011958 Ubiquitin-Specific Peptidase 7 Proteins 0.000 description 1
• 229940126752 Ubiquitin-specific protease 7 inhibitor Drugs 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 101150042678 VAV1 gene Proteins 0.000 description 1
• 102100035071 Vimentin Human genes 0.000 description 1
• 108010065472 Vimentin Proteins 0.000 description 1
• 241000282485 Vulpes vulpes Species 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 108010036639 WW Domain-Containing Oxidoreductase Proteins 0.000 description 1
• 102000012163 WW Domain-Containing Oxidoreductase Human genes 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 108700031763 Xeroderma Pigmentosum Group D Proteins 0.000 description 1
• 102100039044 Zinc finger HIT domain-containing protein 1 Human genes 0.000 description 1
• 102100028482 Zinc finger matrin-type protein 3 Human genes 0.000 description 1
• 102100023442 Zinc finger protein 148 Human genes 0.000 description 1
• 102100028457 Zinc finger protein 319 Human genes 0.000 description 1
• 102100028440 Zinc finger protein 40 Human genes 0.000 description 1
• 102100035809 Zinc finger protein 622 Human genes 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 239000003377 acid catalyst Substances 0.000 description 1
• 108010029777 actin interacting protein 1 Proteins 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 125000002877 alkyl aryl group Chemical group 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 125000003368 amide group Chemical group 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000005122 aminoalkylamino group Chemical group 0.000 description 1
• 201000007538 anal carcinoma Diseases 0.000 description 1
• 201000004612 anterior uveitis Diseases 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 101150059062 apln gene Proteins 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 125000003710 aryl alkyl group Chemical group 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 230000002146 bilateral effect Effects 0.000 description 1
• 201000000053 blastoma Diseases 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 208000015294 blood coagulation disease Diseases 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 125000001246 bromo group Chemical group Br* 0.000 description 1
• 210000001775 bruch membrane Anatomy 0.000 description 1
• 210000001217 buttock Anatomy 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 206010061592 cardiac fibrillation Diseases 0.000 description 1
• 230000009787 cardiac fibrosis Effects 0.000 description 1
• 238000007675 cardiac surgery Methods 0.000 description 1
• 210000001715 carotid artery Anatomy 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 210000000711 cavernous sinus Anatomy 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 208000026915 cervical aortic arch Diseases 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• 239000000544 cholinesterase inhibitor Substances 0.000 description 1
• 210000001612 chondrocyte Anatomy 0.000 description 1
• 208000023819 chronic asthma Diseases 0.000 description 1
• 231100000012 chronic liver injury Toxicity 0.000 description 1
• 230000001886 ciliary effect Effects 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000035850 clinical syndrome Diseases 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000009519 contusion Effects 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 208000021921 corneal disease Diseases 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• NVLDXKCJZRQSDJ-UHFFFAOYSA-L cyclohexane-1,2-diamine;2-(1,2-dihydroxyethyl)-3-hydroxy-5-oxo-2h-furan-4-olate;platinum(2+) Chemical compound [Pt+2].NC1CCCCC1N.OCC(O)C1OC(=O)C([O-])=C1O.OCC(O)C1OC(=O)C([O-])=C1O NVLDXKCJZRQSDJ-UHFFFAOYSA-L 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 230000004340 degenerative myopia Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 201000011190 diabetic macular edema Diseases 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
• 230000009189 diving Effects 0.000 description 1
• 238000011143 downstream manufacturing Methods 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 235000013399 edible fruits Nutrition 0.000 description 1
• 239000008157 edible vegetable oil Substances 0.000 description 1
• 230000001819 effect on gene Effects 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 238000003372 electrophysiological method Methods 0.000 description 1
• 230000010102 embolization Effects 0.000 description 1
• 201000008184 embryoma Diseases 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 201000000523 end stage renal failure Diseases 0.000 description 1
• 201000003914 endometrial carcinoma Diseases 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• CHNUOJQWGUIOLD-NFZZJPOKSA-N epalrestat Chemical compound C=1C=CC=CC=1\C=C(/C)\C=C1/SC(=S)N(CC(O)=O)C1=O CHNUOJQWGUIOLD-NFZZJPOKSA-N 0.000 description 1
• 206010015037 epilepsy Diseases 0.000 description 1
• 201000005619 esophageal carcinoma Diseases 0.000 description 1
• 125000004185 ester group Chemical group 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 125000001033 ether group Chemical group 0.000 description 1
• 208000024519 eye neoplasm Diseases 0.000 description 1
• 210000003191 femoral vein Anatomy 0.000 description 1
• 230000035557 fibrillogenesis Effects 0.000 description 1
• 230000002600 fibrillogenic effect Effects 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 230000003890 fistula Effects 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 230000003325 follicular Effects 0.000 description 1
• 201000003444 follicular lymphoma Diseases 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 101150057053 fzd2 gene Proteins 0.000 description 1
• 229960003980 galantamine Drugs 0.000 description 1
• ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
• ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 230000024924 glomerular filtration Effects 0.000 description 1
• 210000000527 greater trochanter Anatomy 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 201000011066 hemangioma Diseases 0.000 description 1
• 208000018398 hemangioma of choroid Diseases 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 101150003074 hoxa5 gene Proteins 0.000 description 1
• 102000049285 human KMT2A Human genes 0.000 description 1
• 102000045718 human TLR2 Human genes 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• 230000001631 hypertensive effect Effects 0.000 description 1
• 201000001948 hypertensive retinopathy Diseases 0.000 description 1
• 230000036543 hypotension Effects 0.000 description 1
• 230000000642 iatrogenic effect Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000010874 in vitro model Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 238000003046 intermediate neglect of differential overlap Methods 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 208000037906 ischaemic injury Diseases 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 125000000468 ketone group Chemical group 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 201000005264 laryngeal carcinoma Diseases 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 201000005249 lung adenocarcinoma Diseases 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 210000000110 microvilli Anatomy 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 210000002161 motor neuron Anatomy 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 208000025113 myeloid leukemia Diseases 0.000 description 1
• 239000002077 nanosphere Substances 0.000 description 1
• 229940100662 nasal drops Drugs 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 201000003142 neovascular glaucoma Diseases 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 210000000885 nephron Anatomy 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 210000005055 nestin Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000001178 neural stem cell Anatomy 0.000 description 1
• 208000007538 neurilemmoma Diseases 0.000 description 1
• 230000016273 neuron death Effects 0.000 description 1
• 230000004112 neuroprotection Effects 0.000 description 1
• 201000002165 neuroretinitis Diseases 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 230000000414 obstructive effect Effects 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 150000002889 oleic acids Chemical class 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 239000000082 organ preservation Substances 0.000 description 1
• 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 102100030898 p53 apoptosis effector related to PMP-22 Human genes 0.000 description 1
• 102100036520 p53-regulated apoptosis-inducing protein 1 Human genes 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 208000030940 penile carcinoma Diseases 0.000 description 1
• 201000008174 penis carcinoma Diseases 0.000 description 1
• WTWWXOGTJWMJHI-UHFFFAOYSA-N perflubron Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br WTWWXOGTJWMJHI-UHFFFAOYSA-N 0.000 description 1
• 229960001217 perflubron Drugs 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 201000002628 peritoneum cancer Diseases 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• MEUIIHOXOWVKNP-UHFFFAOYSA-N phosphanylformic acid Chemical class OC(P)=O MEUIIHOXOWVKNP-UHFFFAOYSA-N 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• RHDXSLLGPJSSGW-VEGRVEBRSA-N phosphoric acid;(2r,3r,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@@H](O)C=O RHDXSLLGPJSSGW-VEGRVEBRSA-N 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 208000037920 primary disease Diseases 0.000 description 1
• 229940097325 prolactin Drugs 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 108010027883 protein kinase C eta Proteins 0.000 description 1
• 210000000512 proximal kidney tubule Anatomy 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 238000011555 rabbit model Methods 0.000 description 1
• 238000011552 rat model Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 201000002793 renal fibrosis Diseases 0.000 description 1
• 210000005084 renal tissue Anatomy 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 210000001927 retinal artery Anatomy 0.000 description 1
• 208000032253 retinal ischemia Diseases 0.000 description 1
• 230000007441 retrograde transport Effects 0.000 description 1
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
• 201000003804 salivary gland carcinoma Diseases 0.000 description 1
• 201000000306 sarcoidosis Diseases 0.000 description 1
• 230000037390 scarring Effects 0.000 description 1
• 206010039667 schwannoma Diseases 0.000 description 1
• 230000035807 sensation Effects 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000037380 skin damage Effects 0.000 description 1
• 108060007624 small GTPase Proteins 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 208000037804 stenosis Diseases 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 206010043207 temporal arteritis Diseases 0.000 description 1
• 238000011191 terminal modification Methods 0.000 description 1
• 239000005451 thionucleotide Substances 0.000 description 1
• XXYIANZGUOSQHY-XLPZGREQSA-N thymidine 3'-monophosphate Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)C1 XXYIANZGUOSQHY-XLPZGREQSA-N 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 231100000133 toxic exposure Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000031998 transcytosis Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000009752 translational inhibition Effects 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• 231100000588 tumorigenic Toxicity 0.000 description 1
• 230000000381 tumorigenic effect Effects 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 230000036269 ulceration Effects 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 208000012991 uterine carcinoma Diseases 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 208000019553 vascular disease Diseases 0.000 description 1
• 230000006444 vascular growth Effects 0.000 description 1
• 230000002455 vasospastic effect Effects 0.000 description 1
• 230000007998 vessel formation Effects 0.000 description 1
• 210000005048 vimentin Anatomy 0.000 description 1
• 208000006542 von Hippel-Lindau disease Diseases 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 230000037303 wrinkles Effects 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1